Clinical trial · Interventional
Contingency Management to Promote Smoking Abstinence in Cancer Patients
NCT04605458CI-TRIAL-00122453completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Smoking Cessation | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Contingency Management | Combination Product | — | UNRESOLVED |
| Standard Care | Combination Product | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Contingency Management
- interventionNames
- Combination Product: Contingency Management
- type
- ACTIVE_COMPARATOR
- label
- Standard Care
- interventionNames
- Combination Product: Standard Care
Primary outcomes (1)
- measure
- Abstinence Rates as Assessed by Self-report for Past 7 Days, Carbon Monoxide Breath Monitoring and/or Anabasine Testing
- timeFrame
- Changes between the study intake appointment to day of surgery, up to five weeks apart
- description
- Abstinence will be defined by 7 days by self-report of no tobacco products, confirmed by CO breath test less than or equal to 4ppm and/or urine anabasine levels less than or equal to 2 ng/ml
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age 18 or older 2. smoking 1 or more combustible tobacco products per day 3. diagnosed with or suspicion of any type of operable cancer Exclusion Criteria: 1. unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia 2. non-English speaking 3. use of alternative nicotine delivery systems (e.g., e-cigarettes, snus, etc) 4. pregnant women
References
Publications (1)
- DERIVEDRojewski AM, Fucito LM, Baker NL, Palmer AM, Foster MG, Warren GW, Bernstein SL, Toll BA. Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial. BMJ Open. 2021 Jun 29;11(6):e051226. doi: 10.1136/bmjopen-2021-051226. PMID 34187835